Sec Form 4 Filing - EuclidSR Partners, L.P. @ FLUIDIGM CORP - 2011-02-15

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person EuclidSR Partners, L.P. 2. Issuer Name and Ticker or Trading Symbol FLUIDIGM CORP [ FLDM] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 45 ROCKEFELLER PLAZA, SUITE 1410 3. Date of Earliest Transaction (MM/DD/YY) 02/15/2011 (Street) NEW YORK, NY10111 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 02/15/2011 02/15/2011 C( 1 ) 47,400 A 47,400 I See Footnotes ( 3 ) ( 4 ) Common Stock 02/15/2011 02/15/2011 C( 5 ) 320,063 A 367,463 I See Footnotes ( 3 ) ( 4 ) Common Stock 02/15/2011 02/15/2011 C( 5 ) 66,991 A 434,454 I See Footnotes ( 3 ) ( 4 ) Common Stock 02/15/2011 02/15/2011 C( 1 ) 47,400 A 481,854 I See Footnotes ( 4 ) ( 6 ) Common Stock 02/15/2011 02/15/2011 C( 5 ) 320,063 A 801,917 I See Footnotes ( 4 ) ( 6 ) Common Stock 02/15/2011 02/15/2011 C( 5 ) 66,991 A 868,908 I See Footnotes ( 4 ) ( 6 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Series E Preferred Stock ( 2 ) 02/15/2011 02/15/2011 C 47,400 ( 7 ) ( 7 ) Common Stock 47,400 $ 0 821,508 I See Footnotes ( 3 ) ( 4 ) Series C Preferred Stock ( 2 ) 02/15/2011 02/15/2011 C 320,063 ( 8 ) ( 8 ) Common Stock 320,063 $ 0 501,445 I See Footnotes ( 3 ) ( 4 ) Series D Preferred Stock ( 2 ) 02/15/2011 02/15/2011 C 66,991 ( 8 ) ( 8 ) Common Stock 66,991 $ 0 434,454 I See Footnotes ( 3 ) ( 4 ) Series E Preferred Stock ( 2 ) 02/15/2011 02/15/2011 C 47,400 ( 7 ) ( 7 ) Common Stock 47,400 $ 0 387,054 I See Footnotes ( 4 ) ( 6 ) Series C Preferred Stock ( 2 ) 02/15/2011 02/15/2011 C 320,063 ( 8 ) ( 8 ) Common Stock 320,063 $ 0 66,991 I See Footnotes ( 4 ) ( 6 ) Series D Preferred Stock ( 2 ) 02/15/2011 02/15/2011 C 66,991 ( 8 ) ( 8 ) Common Stock 66,991 $ 0 0 I See Footnotes ( 4 ) ( 6 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other EuclidSR Partners, L.P. 45 ROCKEFELLER PLAZA, SUITE 1410 NEW YORK, NY10111 X EuclidSR Biotechnology Partners, L.P. 45 ROCKEFELLER PLAZA, SUITE 1410 NEW YORK, NY10111 X Signatures /s/ William Smith, attorney-in-fact 02/16/2011 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Represents shares of Common Stock issued upon conversion of shares of Series E Preferred Stock on a 1-for-1.300053676865 basis. ( 2 )Not applicable. ( 3 )EuclidSR Partners, L.P., is the record holder of the securities reported. ( 4 )These securities are owned of record by EuclidSR Partners, L.P., for which voting and investment power is shared by Graham D.S. Anderson, Milton J. Pappas, Stephen K. Reidy and Raymond J. Whitaker, each of whom is a gener al partner of EuclidSR Associates, L.P., the general partner of EuclidSR Partners, L.P. Raymond J. Whitaker, a member of the Board of Directors of the Issuer, and each of the other general partners of EuclidSR Associates, L.P. discliams beneficial ownership of these securities except to the extent of his pecuniary interest therein. ( 5 )Represents shares of Common Stock issued upon the conversion of shares of Series C Preferred Stock or Series D Preferred Stock on a 1-for-1 basis. ( 6 )EuclidSR Biotechnology Partners, L.P. is the record holder of the securities reported. ( 7 )Each share of Series E Preferred Stock automatically converted into 1.300053676865 share of Common Stock on February 15, 2011, the closing date of the Issuer's initial public offer (the "Closing) and has no expiration date. ( 8 )Each share of Series C Preferred Stock or Series D Preferred Stock automatically converted into one share of Common Stock on the Closing and has no expiration date.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.